nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexylcaine—SCN3A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0916	0.0935	CbGpPWpGaD
Hexylcaine—SCN2A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.088	0.0898	CbGpPWpGaD
Hexylcaine—SCN10A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0849	0.0866	CbGpPWpGaD
Hexylcaine—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0849	0.0866	CbGpPWpGaD
Hexylcaine—SCN5A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0597	0.0609	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0352	0.0359	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0338	0.0345	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0326	0.0332	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0326	0.0332	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0229	0.0234	CbGpPWpGaD
Hexylcaine—Mitiglinide—PPARG—polycystic ovary syndrome	0.0201	1	CrCbGaD
Hexylcaine—SCN3A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0139	0.0142	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0133	0.0136	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0133	0.0136	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0129	0.0131	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0129	0.0131	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0128	0.013	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0123	0.0126	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0123	0.0126	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0116	0.0119	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0112	0.0114	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0108	0.011	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0108	0.011	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—NRG1—polycystic ovary syndrome	0.0107	0.0109	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00948	0.00968	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00931	0.0095	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00911	0.0093	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00905	0.00923	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00879	0.00897	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00879	0.00897	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00866	0.00883	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—INS—polycystic ovary syndrome	0.00766	0.00782	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00758	0.00773	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—IGF1—polycystic ovary syndrome	0.00741	0.00756	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00618	0.0063	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00591	0.00603	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00526	0.00537	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—DLG4—polycystic ovary syndrome	0.00525	0.00536	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—DLG4—polycystic ovary syndrome	0.00504	0.00515	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—DLG4—polycystic ovary syndrome	0.00486	0.00496	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—DLG4—polycystic ovary syndrome	0.00486	0.00496	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00425	0.00434	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00375	0.00382	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00372	0.00379	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—DLG4—polycystic ovary syndrome	0.0036	0.00367	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00357	0.00364	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00351	0.00358	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00347	0.00354	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00347	0.00354	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00344	0.00351	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00344	0.00351	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—DLG4—polycystic ovary syndrome	0.00342	0.00349	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00337	0.00344	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00325	0.00332	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00325	0.00332	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00281	0.00286	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.0027	0.00275	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.0026	0.00265	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.0026	0.00265	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00244	0.00249	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00242	0.00247	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—LEP—polycystic ovary syndrome	0.00231	0.00236	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00229	0.00233	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—LEP—polycystic ovary syndrome	0.00222	0.00226	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.00214	0.00218	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—LEP—polycystic ovary syndrome	0.00214	0.00218	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00204	0.00208	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00201	0.00205	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.00197	0.00201	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00193	0.00197	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00191	0.00195	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.00189	0.00193	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00186	0.0019	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00186	0.0019	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00183	0.00187	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00183	0.00186	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.00183	0.00186	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.00183	0.00186	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00177	0.0018	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00177	0.0018	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00175	0.00178	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00168	0.00171	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00162	0.00165	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00162	0.00165	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.0015	0.00153	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00141	0.00144	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00131	0.00134	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.00128	0.00131	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00125	0.00127	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00124	0.00127	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.00121	0.00123	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.0012	0.00122	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.00116	0.00118	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00115	0.00118	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00115	0.00118	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00114	0.00116	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.00112	0.00114	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.00112	0.00114	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000862	0.000879	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.000828	0.000845	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000812	0.000828	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000798	0.000815	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000798	0.000815	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000787	0.000803	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000561	0.000573	CbGpPWpGaD
